Oct 18, 2023 / 12:00PM GMT
Presentations Call
Oct 18, 2023 / 12:00PM GMT
=====================
Corporate Participants
=====================
* David Connolly
Rhythm Pharmaceuticals, Inc. - Head of IR & Corporate Communications
* David P. Meeker
Rhythm Pharmaceuticals, Inc. - Chairman, President & CEO
=====================
Conference Call Participants
=====================
* Corinne Jenkins
Goldman Sachs Group, Inc., Research Division - VP
* Dae Gon Ha
Stifel, Nicolaus & Company, Incorporated, Research Division - Research Analyst
* Derek Christian Archila
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst
* Jeff Hung
Morgan Stanley, Research Division - Equity Analyst
* Joseph Robert Stringer
Needham & Company, LLC, Research Division - Senior Analyst
* Michael John Higgins
Ladenburg Thalmann & Co. Inc., Research Division - MD & Senior Biopharmaceuticals Equity Research Analyst
* Philip M. Nadeau
TD Cowen, Research Division - MD
Rhythm Pharmaceuticals Inc
(MEX:RYTM)
MXN
1,866.76
(0%)
Market Cap: 132.68 Bil
Enterprise Value: 128.79 Bil
PE Ratio: 0
PB Ratio: 61.48
GF Score: 56/100 Rhythm Pharmaceuticals Inc To Discuss Data Presentations Call Transcript
Oct 18, 2023 / 12:00PM GMT
Release Date Price:
MXN466.27
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot